GeoVax Files to Sell 1.61M Shares of Common Stock for Holders
Top Premarket Decliners
Biomea Fusion (BMEA) shares slumped 61% Friday premarket after the company said that the US Food and Drug Administration placed a full clinical hold on the company's diabetes program. Logistic Propert
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersOneMedNet (NASDAQ:ONMD) stock moved upwards by 15.6% to $1.7 during Thursday's after-market session. The company's market cap stands at $40.5 million. 23andMe Holding (NASDAQ:ME) shares increas
NVIDIA, Dell Technologies, Super Micro Computer Among Premarket Gainers' Pack
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersSharps Technology (NASDAQ:STSS) stock increased by 56.5% to $0.4 during Wednesday's after-market session. The market value of their outstanding shares is at $6.3 million. Geovax Labs (NASDAQ:GO
Earnings Call Summary | GeoVax Labs(GOVX.US) Q1 2024 Earnings Conference
The following is a summary of the GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript:Financial Performance:GeoVax reported a net loss of $5.9 million for Q1 2024, or $2.47 per share, compared t
10-Q: Quarterly report
Notable Earnings After Tuesday's Close
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Tesla CEO Elon Musk does not seem to agree with Republicans at least on one thing. On Wednesday, the billionaire, true to his credentials as a tech pioneer, unequivocally backed the mRNA technology, w
Express News | WHO's Tedros Adhanom Ghebreyesus Posts On X "In #DRC Alone, More Than 4500 Cases of #mpox and Almost 300 Deaths Have Been Reported This Year. That Is Triple the Number Reported at This Time Last Year. The Recent Surge in Cases and Deaths Among Children Is
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersProtara Therapeutics (NASDAQ:TARA) stock increased by 40.3% to $5.64 during Friday's pre-market session. The market value of their outstanding shares is at $64.4 million. Candel Therapeutics (N
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
GeoVax Labs, Inc. (Nasdaq: GOVX) today announced that its Chief Scientific Officer, Mark Newman, PhD, presented data on GEO-CM04S1, the Company's next-generation Covid-19 vaccine candidate, during the 24th Annual World Vaccine Congress in Washington, DC.
GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress
ATLANTA, GA, March 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious di
GeoVax to Present at the 36th Annual Roth Conference
ATLANTA, GA, March 12, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious d
Noble Financial Reaffirms Their Buy Rating on GeoVax Labs (GOVX)
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production Being Developed for GeoVax MVA-Based Vaccines ATLANTA, GA, March 06, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasda
Express News | GeoVax Labs Inc Files For Mixed Shelf Of Up To $100M
Earnings Call Summary | GeoVax Labs(GOVX.US) Q4 2023 Earnings Conference
The following is a summary of the GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript:Financial Performance:GeoVax Labs reported a net loss for 2023 of $265 million, or $14.29 per share, driven
Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX), Madrigal Pharmaceuticals (MDGL) and Spyre Therapeutics (SYRE)
GeoVax GAAP EPS of -$14.29 Beats by $0.26
No Data